Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Bladder Cancer |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of
Synthetic Magnetic Resonance Imaging.
Acad Radiol. 2024 Mar 27:S1076-6332(24)00153-3. doi: 10.1016/j.acra.2024.
PubMed
Abstract available
Narrow Bandgap Schottky Heterojunction Sonosensitizer with High Electron-Hole
Separation Boosted Sonodynamic Therapy in Bladder Cancer.
Adv Mater. 2024 Mar 28:e2401252. doi: 10.1002/adma.202401252.
PubMed
Abstract available
Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin
Sensitivity in Bladder Cancer.
Adv Sci (Weinh). 2024 Mar 25:e2310146. doi: 10.1002/advs.202310146.
PubMed
Abstract available
[CpG-ODN instillation boosts ICAM-1 expression in an orthotopic murine UCC model:
immunohistochemical evaluation of the local response to immunostimulatory DNA].
Aktuelle Urol. 2024;55:154-160.
PubMed
Abstract available
[Not Available].
Aktuelle Urol. 2024;55:100-102.
PubMed
The Mechanism of miR-29 in Bladder Cancer Released by Exosomes into Brain
Microglia to Promote M2 Polarization and Angiogenesis in Brain Metastasis of
Bladder Cancer.
Altern Ther Health Med. 2024 Mar 22:AT10593.
PubMed
Abstract available
Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated
Genes in Bladder Cancer.
Altern Ther Health Med. 2024 Mar 22:AT10582.
PubMed
Abstract available
Assessment of Therapeutic Effects of Combined Treatment With Cisplatin and
Anti-mouse Programmed Death (PD)-1 Antibody in a Mouse Urothelial Cancer Model.
Anticancer Res. 2024;44:1417-1423.
PubMed
Abstract available
Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for
Advanced Urothelial Carcinoma: The UROKYU Study.
Anticancer Res. 2024;44:1675-1681.
PubMed
Abstract available
Redox System and Oxidative Stress-Targeted Therapeutic Approaches in Bladder
Cancer.
Antioxidants (Basel). 2024;13:287.
PubMed
Abstract available
The impact of multidisciplinary cancer meetings in guiding treatment intent in
patients with upper tract urothelial carcinoma.
Asia Pac J Clin Oncol. 2024;20:41-45.
PubMed
Abstract available
Cytotoxicity and Apoptosis Studies of Brucein D against T24 Bladder Cancer Cells.
Asian Pac J Cancer Prev. 2024;25:921-930.
PubMed
Abstract available
Ferrous Selenide Stabilized Black Phosphorus Heterojunction Sonosensitizer for MR
Imaging-Guided Sonodynamic Therapy of Bladder Cancer.
Biomater Res. 2024;28:0014.
PubMed
Abstract available
Retracted: lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer
through Enhancing IQGAP3 and CDCA5 Expression.
Biomed Res Int. 2024;2024:9783095.
PubMed
Abstract available
Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for
Bladder Cancer: Efficacy and Synergistic Effects.
Biomedicines. 2024;12:647.
PubMed
Abstract available
Development of the multivariate administrative data cystectomy model and its
impact on misclassification bias.
BMC Med Res Methodol. 2024;24:73.
PubMed
Abstract available
Quantitative differentiation of non-invasive bladder urothelial carcinoma and
inverted papilloma based on CT urography.
BMC Urol. 2024;24:73.
PubMed
Abstract available
Preliminary findings on the development of a predictive model for BLCA based on
disulfidptosis-associated IncRNAs signature.
BMC Urol. 2024;24:69.
PubMed
Abstract available
Nomogram for customized recurrence prediction in primary non-muscle-invasive
bladder cancer based on routine blood and urine parameters.
BMC Urol. 2024;24:67.
PubMed
Abstract available
Chronic pelvic pain and dysmenorrhea disguising a rare submucosal leiomyoma of
the urinary bladder.
BMJ Case Rep. 2024;17:e258971.
PubMed
Abstract available
Multi-omics comprehensive analysis reveals the predictive value of
N6-methyladenosine- related genes in prognosis and immune escape of bladder
cancer.
Cancer Biomark. 2024 Jan 25. doi: 10.3233/CBM-230286.
PubMed
Abstract available
The Effect of Retinoic Acid on Arsenite-Transformed Malignant UROtsa Bladder
Cancer Cells: In Vitro Model of Basal Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2024;16:1178.
PubMed
Abstract available
CD44 in Bladder Cancer.
Cancers (Basel). 2024;16:1195.
PubMed
Abstract available
A Prognostic Index Derived From LASSO-Selected Preoperative Inflammation and
Nutritional Markers for Non-Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2024 Feb 29:102061. doi: 10.1016/j.clgc.2024.
PubMed
Abstract available
The Effect of Lymphovascular Invasion on Short-Term Tumor Recurrence and
Progression in Stage T1 Bladder Cancer.
Cureus. 2024;16:e54844.
PubMed
Abstract available
Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and
Association with Molecular Subtypes-Preliminary Report.
Curr Issues Mol Biol. 2024;46:2456-2467.
PubMed
Abstract available
SGLT2 inhibition and three urological cancers: Up-to-date results.
Diabetes Metab Res Rev. 2024;40:e3797.
PubMed
Abstract available
Unlocking the Therapeutic Potential of LncRNA BLACAT1 in Hypopharynx Squamous
Cell Carcinoma.
Discov Med. 2024;36:546-558.
PubMed
Abstract available
The Assessment of SF-36 Survey for Quality-of-Life Measurement after Radical
Cystectomy for Muscle-Invasive Bladder Cancer: A Systematic Review.
Diseases. 2024;12:56.
PubMed
Abstract available
Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan.
Environ Int. 2024;185:108542.
PubMed
Abstract available
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in
patients with solid tumors (POD1UM-203).
ESMO Open. 2024;9:102387.
PubMed
Abstract available
Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol. 2024 Mar 26:S0302-2838(24)02206-1. doi: 10.1016/j.eururo.2024.
PubMed
Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in
Preclinical Models of Bladder Cancer.
Eur Urol. 2024 Mar 23:S0302-2838(24)02231-0. doi: 10.1016/j.eururo.2024.
PubMed
A Fully Automated Artificial Intelligence System to Assist Pathologists'
Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from
Digitized Urine Cytology Slides Using Deep Learning.
Eur Urol Oncol. 2024;7:258-265.
PubMed
Abstract available
Antibiotic therapy impact on intravesical BCG therapy efficacy for high-risk
localized bladder cancer treatment.
Front Oncol. 2024;13:1240378.
PubMed
Abstract available
Effectiveness of Preoperative Immunonutrition in Improving Surgical Outcomes
after Radical Cystectomy for Bladder Cancer: Study Protocol for a Multicentre,
Open-Label, Randomised Trial (INu-RC).
Healthcare (Basel). 2024;12:696.
PubMed
Abstract available
The mechanism of the contribution of ICAM-1 to epithelial-mesenchymal transition
(EMT) in bladder cancer.
Hum Cell. 2024 Mar 22. doi: 10.1007/s13577-024-01053.
PubMed
Abstract available
Reply to "Knowledge-map analysis and bladder cancer immunotherapy: Comment".
Hum Vaccin Immunother. 2024;20:2325756.
PubMed
Enhancing recurrence risk prediction for bladder cancer using multi-sequence MRI
radiomics.
Insights Imaging. 2024;15:88.
PubMed
Abstract available
Strategies for Overcoming Immune Evasion in Bladder Cancer.
Int J Mol Sci. 2024;25:3105.
PubMed
Abstract available
Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review.
Int J Mol Sci. 2024;25:3347.
PubMed
Abstract available
Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder
Cancer.
Int J Mol Sci. 2024;25:3462.
PubMed
Abstract available
Plasma Levels of Pentraxin 3: A Potential Prognostic Biomarker in Urinary Bladder
Cancer Patients.
Int J Mol Sci. 2024;25:3473.
PubMed
Abstract available
Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing
Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper
Tract Urothelial Carcinoma.
Int J Mol Sci. 2024;25:3492.
PubMed
Abstract available
Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of
high-grade T1 bladder cancer.
Int Urol Nephrol. 2024 Mar 26. doi: 10.1007/s11255-024-03971.
PubMed
Abstract available
Impacts of enhanced recovery after surgery nursing interventions on wound
infection and complications following bladder cancer surgery: A meta-analysis.
Int Wound J. 2024;21:e14781.
PubMed
Abstract available
Long-term renal function following radical cystectomy and ileal conduit creation.
Ir J Med Sci. 2024;193:639-644.
PubMed
Abstract available
Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method
for bladder cancers.
J Cancer Res Clin Oncol. 2024;150:169.
PubMed
Abstract available
Identifying the supportive care needs of people affected by non-muscle invasive
bladder cancer: An integrative systematic review.
J Cancer Surviv. 2024 Mar 23. doi: 10.1007/s11764-024-01558.
PubMed
Abstract available
Immunochemistry-based quantification of tumor-infiltrating lymphocytes and
immunoscore as prognostic biomarkers in bladder cancer.
J Egypt Natl Canc Inst. 2024;36:9.
PubMed
Abstract available
Trihalomethanes in global drinking water: Distributions, risk assessments, and
attributable disease burden of bladder cancer.
J Hazard Mater. 2024;469:133760.
PubMed
Abstract available
Electrospun nanofibrous mats loaded with gemcitabine and cisplatin suppress
bladder tumor growth by improving the tumor immune microenvironment.
J Mater Sci Mater Med. 2024;35:21.
PubMed
Abstract available
Recurrent bladder leiomyoma: a case report.
J Med Case Rep. 2024;18:173.
PubMed
Abstract available
Challenges, considerations, and approaches for developing a cost-effectiveness
model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a
spotlight on nivolumab versus placebo.
J Med Econ. 2024;27:473-481.
PubMed
Abstract available
Identification of novel protein biomarkers from the blood and urine for the early
diagnosis of bladder cancer via proximity extension analysis.
J Transl Med. 2024;22:314.
PubMed
Abstract available
J Wound Ostomy Continence Nurs
Parastomal Hernia Following Ileal Conduit: Incidence, Risk Factors, and
Health-Related Quality of Life.
J Wound Ostomy Continence Nurs. 2024;51:126-131.
PubMed
Abstract available
Retraction: 'ASPM predicts poor prognosis and regulates cell proliferation in
bladder cancer'. Zhen-Ya Gao, Fang Yu, Huan-Xia Jia, Zhuo Ye, Shi-Jie Yao,
Kaohsiung J Med Sci. 2020; 36: 1021-1029 (https://doi.org/10.1002/kjm2.12284).
Kaohsiung J Med Sci. 2024 Mar 28. doi: 10.1002/kjm2.12825.
PubMed
Abstract available
CircITGA7 regulates malignant phenotypes in bladder cancer cells via targeting
miR-330-3p/KLF10 axis.
Kaohsiung J Med Sci. 2024 Mar 25. doi: 10.1002/kjm2.12821.
PubMed
Abstract available
Comparison of Oncological Outcomes between Transperitoneal and Retroperitoneal
Approaches in Laparoscopic Nephroureterectomies for Upper Tract Urothelial
Carcinoma.
Medicina (Kaunas). 2024;60:421.
PubMed
Abstract available
Immune checkpoint inhibitor-related adrenal hypofunction and Psoriasisby induced
by tislelizumab: A case report and review of literature.
Medicine (Baltimore). 2024;103:e37562.
PubMed
Abstract available
Arab world's impact on bladder cancer research and opportunities for growth: A
bibliometric review study.
Medicine (Baltimore). 2024;103:e37554.
PubMed
Abstract available
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial
Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
Mod Pathol. 2024;37:100424.
PubMed
Abstract available
Spatial relationships in the urothelial and head and neck tumor microenvironment
predict response to combination immune checkpoint inhibitors.
Nat Commun. 2024;15:2538.
PubMed
Abstract available
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new
directions.
Nat Rev Clin Oncol. 2024;21:312-329.
PubMed
Abstract available
Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift.
Nat Rev Clin Oncol. 2024;21:255-256.
PubMed
Bladder cancer: An Update.
Nursing. 2024;54:27-39.
PubMed
Abstract available
Bladder cancer: An Update.
Nursing. 2024;54:39-40.
PubMed
Comparison of red and green light for treating non-muscle invasive bladder cancer
in rats using singlet oxygen-cleavable prodrugs with PPIX-PDT.
Photochem Photobiol. 2024 Mar 27. doi: 10.1111/php.13933.
PubMed
Abstract available
Natural products and derivatives in renal, urothelial and testicular cancers:
Targeting signaling pathways and therapeutic potential.
Phytomedicine. 2024;127:155503.
PubMed
Abstract available
Association of spironolactone use with risk of urinary tract cancer in the
general population: A matched population-based cohort study.
PLoS One. 2024;19:e0300391.
PubMed
Abstract available
[BCG instillation sepsis in bladder carcinoma].
Praxis (Bern 1994). 2024;113:44.
PubMed
Endothelial cell proliferation and vascular patterns in urothelial carcinoma.
Rom J Morphol Embryol. 2024;65:61-67.
PubMed
Abstract available
Evaluating a combination treatment of NK cells and reovirus against bladder
cancer cells using an in vitro assay to simulate intravesical therapy.
Sci Rep. 2024;14:7390.
PubMed
Abstract available
Examining the causal association between psoriasis and bladder cancer: A
two-sample Mendelian randomization analysis.
Skin Res Technol. 2024;30:e13663.
PubMed
Abstract available
Longer time to radical cystectomy in patients treated with neoadjuvant
chemotherapy is associated with worse oncological outcomes.
Urol Oncol. 2024;42:117.
PubMed
Abstract available
Maximizing efficiency and ensuring safety: Exploring the outcomes of 2
consecutive open radical cystectomies by the same team within a single surgical
day.
Urol Oncol. 2024;42:118.
PubMed
Abstract available
Blood-based liquid biopsy: A promising noninvasive test in diagnosis,
surveillance, and prognosis of patients with upper tract urothelial carcinoma.
Urol Oncol. 2024;42:118.
PubMed
Abstract available
Symptomatic and functional recovery after transurethral resection of bladder
tumor: Data from ecological momentary symptom assessment.
Urol Oncol. 2024;42:117.
PubMed
Abstract available
Assessing pentafecta outcomes post radical cystectomy: A tertiary care center
study.
Urologia. 2024;91:49-54.
PubMed
Abstract available
Role of multiparametric MRI in predicting muscle invasiveness in urinary bladder
neoplasms with pathological correlations.
Urologia. 2024;91:55-60.
PubMed
Abstract available
Prediction of pathological up-staging after radical nephroureterectomy in
patients with upper tract urothelial carcinoma.
World J Urol. 2024;42:192.
PubMed
Abstract available
Letter to the editor for the article "Nephron-sparing ureteroscopic surgery vs.
radical nephroureterectomy: comparable survival-outcomes in upper tract
urothelial carcinoma".
World J Urol. 2024;42:198.
PubMed
Thank you for your interest in scientific medicine.